Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis

Canadian Journal of Cardiology

Volumn 13, Issue 5, 1997, Pages 533-535

  Polasek, J ^a,b  

^a Etobicoke General Hospital   (Canada)

^b NONE   (Canada)

Author keywords

Acetylsalicylic acid; Atherosclerosis; Lysosomes; Platelet activation; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL;

ARTERY THROMBOSIS; ARTICLE; DRUG EFFICACY; HEART INFARCTION; HUMAN; LYSOSOME; STROKE; THROMBOCYTE;

ARTERIOSCLEROSIS; ASPIRIN; CEREBROVASCULAR DISORDERS; DRUG INTERACTIONS; HUMANS; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; VITAMIN E;

EID: 0030919854     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Prentice CR. Antithrombotic therapy in the secondary prevention of myocardial infarction. Am J Cardiol 1993;72:175G-80G.
2. Bamett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischémie stroke. N Engl J Med 1995;332:238-48;333:460.
3. Ghooi RB, Thatte SM, Joshi PS. The mechanism of action of aspirin -is there anything beyond cyclo-oxygenase? Med Hypotheses 1995;44:77-80.
4. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein Ilb/IIIa receptors in cardiovascular medicine. N Engl ] Med 1995;332:1553-9.
5. Shute WE, Taub HJ. Vitamin E for Ailing and Healthy Hearts. New York: Pyramid Books, 1969:7-208.
6. Beamish RE. Vitamin E - Then and now. Can J Cardiol 1993;9:29-31.
7. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 1991;10:466-73.
8. Stephens NO, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
9. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y.Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N EnglJ Med 1996;334:1156-62.
10. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologie Studies of the Elderly. Am J Clin Nutr 1996;64:190-6.
11. The (HOPE) Heart Outcomes Prevention Evaluation Study: The design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996;12:127-37.
12. Collaborative group of the Primary Prevention Project. Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. J Cardiovasc Risk 1995;2:137-42.
13. Buchanan MR, Butt RW, Hirsh J, Markham BA, Nazir DJ. Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate. Prostaglandins Leukot Med 1986;21:157-68.
14. Pritchard KA, Greco NJ, Pangamala RV. Effect of dietary vitamin E on the production of platelet 12-hydroxy-eicosatetraenoic acid (12-HETE). Thromb Haemost 1986;55:6-7.
15. Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically. Can J Cardiol 1995;ll:221-7.
16. Helgason CM, Tortorice KL, Winkler SR, Penney DW, Schüler JJ. Aspirin response and failure in cerebral infarction. Stroke 1993;24:345-50;24:1259-61.
17. Pappas JM, Westengard JC, Bull BS. Population variability in the effect of aspirin on platelet function. Arch Pathol Lab Med 1994:118:801-4.
18. Chan AC, Tran K, Raynor T, Ganz PR, Chow CK. Regeneration of vitamin E in human platelets. J Biol Chem 1991;266:17290-5.
19. Jandak J, Steiner M, Richardson PD. Alpha-tocopherol, an effective inhibitor of platelet adhesion. Blood 1989:73:141-9.
20. Violi F, Pratico D, Ghiselli A, et al. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentrations. Atherosclerosis 1990;82:247-52.
21. Polasek J. Lysosomal concept of platelet secretion - revisited. Eur J Haematol 1989;(Suppl 50).
22. Kinlough-Rathbone RL, Packham MA, Guccione MA, Richardson M, Harfenist EJ, Mustard JF. Characteristics of thrombin degranulated human platelets: Development of a method that does not use proteolytic enzymes for deaggregation. Thromb Haemost 1991:65:403-10.
23. Rupar CA, Albo S, Whitehall JD. Rat liver lysosome membranes are enriched in alpha-tocopherol. Biochem Cell Biol 1992;70:486-8.
24. Leus NF, Metelitsyna IP. [Effect of vitamins A and E on the structural-functional state of retinal lysosomes.] Ukr Biokhim Zh j 1987;59:75-9.
25. Lin CT, Chen LH. Ultrastructural and lysosomal enzyme studies of skeletal muscle and myocardium in rats with long-term vitamin E deficiency. Pathology 1982;14:375-82.
26. Weglicki WB, Ruth RC, Ovens K, Griffin HD, Waite BM. Changes ! in lipid composition of triton-filled lysosomes. Association with activation of acid-active lipases and phospholipases. Biochim Biophys Acta 1974;337:145-52.
27. Hashizume T, Yamaguchi H, Kawamoto A, Tamura A, Sato T, Fujii 1 T. Lipid peroxide makes rabbit platelet hyper-aggregable to agonist through phospholipase A-2 activation. Arch Biochem Biophys | 1991;289:47-52.
28. Salonen R, Nyyssonen K, Porkkala E, et al. Kuopio Atherosclerosis . Prevention Study (KAPS). A population based primary preventive i trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758-64.
29. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl 1 Med 1995;333:1301-7.
30. Sacks FM, Pasternak RC, Gibson CM, Rosner B, Stone PH. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Lancet 1994:344:1182-6.
31. White JG. Platelets and atherosclerosis. Eur J Clin Invest 1994;24(Suppl l):25-9.
32. Davies MJ. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 1996;82:l-32.
33. Polasek J, Kubisz P. Acid phosphatases and platelet factor 3. Scand J Haematol 1968;5:390-400.
34. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992;18:445-56.
35. Sumner WT, Monroe DM, Huffman M. Variability in platelet procoagulant activity in healthy volunteers. Thromb Res 1996;81:533-43.
36. Grand round. Platelet activation and arterial thrombosis. Lancet 1994:344:991-5.
37. Steiner M, Giant: M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischémie attacks. Am J Clin Nutr 1995;62(Suppl):1381S-4S.
38. Polasek J. Aspirin, vitamin E and heart attack prevention. Thromb Haernost 1996;75:863. (Lett)